PARIS (Reuters) - The French government needs guarantees from drugmaker Sanofi that production of its popular Doliprane ...

Sanofi announced on Monday that it had entered into exclusive negotiations with US investment fund CD&R to sell it a majority ...

French drugmaker Sanofi's Monday confirmation that it plans to sell a controlling stake in its over-the-counter unit to a US ...

Sanofi confirmed on Monday plans to sell a controlling stake in its over-the-counter unit to a US investment fund, ...

Sanofi entered into exclusive talks to sell its consumer-healthcare business Opella to Clayton Dubilier & Rice in a deal that ...

The proposed sale turned into a real political issue because Opella's products include Doliprane, the best-selling medicine ...

The sale of a French drugmaker to an American group is likely to now go ahead after French Economy Minister Antoine Armand ...

Politicians from across the political spectrum are up in arms over healthcare giant Sanofi's plans to sell France's ...

Sanofi and CD&R have entered exclusive negotiations for CD&R to acquire a 50% controlling stake in Opella, Sanofi’s consumer ...

The European Commission has approved 128 million euros ($139 million) of Swedish state aid to help steelmaker SSAB ...

Unions in France are planning a walkout over the planned sale of the pharmaceutical company that makes popular painkiller ...

PARIS, Oct 14 (Reuters) - The French government needs guarantees from drugmaker Sanofi (SASY.PA), opens new tab that production of its popular Doliprane painkiller will stay in France to allow the ...